We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$3.27B
AUM Growth
+$208M
Cap. Flow
+$171M
Cap. Flow %
5.23%
Top 10 Hldgs %
30.91%
Holding
183
New
7
Increased
120
Reduced
43
Closed
13

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$30.9M
2
AZTA icon
Azenta
AZTA
+$21M
3
INDI icon
indie Semiconductor
INDI
+$20.4M
4
EVH icon
Evolent Health
EVH
+$20.1M
5
SPT icon
Sprout Social
SPT
+$17.6M

Top Sells

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$30.7M
2
KLIC icon
Kulicke & Soffa
KLIC
+$20.5M
3
ENPH icon
Enphase Energy
ENPH
+$17.4M
4
CSGP icon
CoStar Group
CSGP
+$11.4M
5
LTH icon
Life Time Group Holdings
LTH
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 40.66%
2 Healthcare 20.31%
3 Industrials 13.2%
4 Consumer Discretionary 8.69%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLNE icon
101
Clean Energy Fuels
CLNE
$379M
$8.53M 0.26%
1,640,831
+177,103
+12% +$1.09M
RCUS icon
102
Arcus Biosciences
RCUS
$3.69B
$8.49M 0.26%
410,480
+67,145
+20% +$1.85M
MASS icon
103
908 Devices
MASS
$415M
$8.42M 0.26%
1,104,904
+137,540
+14% +$1.66M
VICR icon
104
Vicor
VICR
$9.83B
$8.26M 0.25%
153,644
-58,104
-27% -$3.06M
PAR icon
105
PAR Technology
PAR
$737M
$7.97M 0.24%
305,588
+125,588
+70% +$3.23M
OSIS icon
106
OSI Systems
OSIS
$3.82B
$7.75M 0.24%
97,426
-16,223
-14% -$1.32M
NTLA icon
107
Intellia Therapeutics
NTLA
$1.69B
$7.59M 0.23%
217,623
+66,788
+44% +$3.18M
KNSA icon
108
Kiniksa Pharmaceuticals
KNSA
$6.04B
$7.55M 0.23%
504,193
-48,157
-9% -$701K
ONTO icon
109
Onto Innovation
ONTO
$15.5B
$7.5M 0.23%
110,088
+17,381
+19% +$1.25M
CSSE
110
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$7.06M 0.22%
1,379,179
+91,214
+7% +$579K
QLYS icon
111
Qualys
QLYS
$6.5B
$6.96M 0.21%
62,039
+10,844
+21% +$1.35M
EPAM icon
112
EPAM Systems
EPAM
$5.16B
$6.86M 0.21%
20,937
+2,431
+13% +$827K
TTGT icon
113
TechTarget
TTGT
$272M
$6.82M 0.21%
154,873
+26,525
+21% +$1.39M
RVNC
114
DELISTED
Revance Therapeutics, Inc.
RVNC
$6.43M 0.2%
348,064
+103,147
+42% +$2.36M
BEAM icon
115
Beam Therapeutics
BEAM
$2.8B
$6.41M 0.2%
163,790
+53,355
+48% +$2.39M
AXTI icon
116
AXT Inc
AXTI
$4.79B
$6.28M 0.19%
1,433,444
+417,483
+41% +$2.04M
KNSL icon
117
Kinsale Capital Group
KNSL
$8.57B
$6.18M 0.19%
23,645
-2,718
-10% -$783K
CRVL icon
118
CorVel
CRVL
$3.11B
$6.17M 0.19%
127,410
+13,533
+12% +$674K
FATE icon
119
Fate Therapeutics
FATE
$316M
$6.08M 0.19%
602,153
+275,734
+84% +$5.18M
ZYME icon
120
Zymeworks
ZYME
$1.72B
$5.8M 0.18%
738,448
+150,640
+26% +$1.06M
MLAB icon
121
Mesa Laboratories
MLAB
$614M
$5.63M 0.17%
33,894
-1,001
-3% -$157K
SLAB icon
122
Silicon Laboratories
SLAB
$7.2B
$5.61M 0.17%
41,370
+7,895
+24% +$1.04M
GO icon
123
Grocery Outlet
GO
$977M
$5.56M 0.17%
190,317
+67,459
+55% +$2.12M
PACB icon
124
Pacific Biosciences
PACB
$361M
$5.54M 0.17%
677,158
+102,969
+18% +$887K
AMWL icon
125
American Well
AMWL
$225M
$5.36M 0.16%
94,724
+11,247
+13% +$810K
3 4
5
6 7

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Granahan Investment Management held 183 positions worth $3.27B, up 6.8% from $3.06B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Granahan Investment Management deployed $171M of net new capital in Q4 2022, opening 7 new positions and adding to 120 existing holdings. Its largest new stake was RB Global: 530,634 shares worth $30.7M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $30.7M trimmed.

  • Granahan Investment Management's largest Q4 2022 buy was RB Global: 530,634 shares worth $30.7M.
  • Granahan Investment Management added most to Azenta in Q4 2022, an estimated $21M increase.
  • Granahan Investment Management's biggest Q4 2022 reduction was Axon Enterprise, cutting an estimated $30.7M.
  • Granahan Investment Management fully exited Kulicke & Soffa in Q4 2022, selling an estimated $20.5M.
  • Granahan Investment Management's ten largest holdings make up 31% of its $3.27B portfolio in Q4 2022.
  • Granahan Investment Management opened 7 new positions and closed 13 in Q4 2022.
  • Granahan Investment Management's portfolio value rose 6.8% quarter-over-quarter to $3.27B.

Based on Granahan Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.